Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Treatment with the Immunomodulator FTY720 (Fingolimod) Significantly Reduces Renal Inflammation in Murine Unilateral Ureteral Obstruction.
Glial cells suppress postencephalitic CD8(+) T lymphocytes through PD-L1.
Testicular hypofunction and multiple sclerosis: Cause or consequence? Author's reply.
Visual pathway abnormalities were found in most multiple sclerosis patients despite history of previous optic neuritis.
Autonomic dysfunction in multiple sclerosis presenting with postural orthostatic tachycardia.
Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in multiple sclerosis patients.
Confounding Parameters in Pre-clinical Assessment of Blood-brain Barrier Permeation: An Overview With Emphasis on Species Differences and Effect of Disease States.
Multiple sclerosis. Recent modalities of treatment.
Fingolimod (FTY720) enhances hippocampal synaptic plasticity and memory in Huntington's disease by preventing p75NTR up-regulation and astrocyte-mediated inflammation.
Damping of monocular pendular nystagmus with vibration in a patient with multiple sclerosis.
Human oligodendrocytes in remyelination research.
A 60-year follow-up of the incidence and prevalence of multiple sclerosis in Hordaland County, Western Norway.
B cell VLA-4-deficiency reduces leukocyte recruitment and susceptibility to central nervous system autoimmunity.
Articulation time does not affect speeded cognitive performance in multiple sclerosis.
Statistical colocalization of genetic risk variants for related autoimmune diseases in the context of common controls.
Oral drugs in multiple sclerosis therapy: an overview and a critical appraisal.
Effects of exercise on Irisin, BDNF and IL-6 serum levels in patients with progressive multiple sclerosis.
Intranetwork and internetwork functional connectivity abnormalities in pediatric multiple sclerosis.
Th17 cells in central nervous system autoimmunity.
In vivo immunomodulatory effect of the lectin from edible mushroom Agaricus bisporus.
Human Umbilical Tissue-Derived Cells Promote Synapse Formation and Neurite Outgrowth via Thrombospondin Family Proteins.
No evidence of a link between multiple sclerosis and the vaccine against the human papillomavirus.
Randomized controlled trial of a teleconference fatigue management plus physical activity intervention in adults with multiple sclerosis: rationale and research protocol.
Erythropoietin: new directions for the nervous system.
Tumor necrosis factor polymorphisms associated with tumor necrosis factor production influence the risk of idiopathic intermediate uveitis.
Pages
« first
‹ previous
…
430
431
432
433
434
435
436
437
438
…
next ›
last »